Bernstein Harold sold MAZE
March 20, 2026 · Form 4 insider transaction
Bernstein Harold sold 3,795 shares of Maze Therapeutics, Inc. at $49.32 per share, a transaction worth $187.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,795
Price
$49.32
Total value
$187.2K
InsiderBernstein Harold
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 20, 2026
Filing dateMarch 20, 2026
Shares owned after5,044
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.78 to $49.77 per share, inclusive.